Source: globenewswire.com

Followers on Owler

163

Annual Revenue

$100K-5.0M

Employees

25-100

President & CEO

Robert Connelly

CEO Approval Rating

86/100

Elicio is a Massachusetts-based clinical-stage biotechnology company that researches and develops novel immunotherapies for the treatment of cancer.

Elicio received $20M in Private Placement Funding